Report Detail

Pharma & Healthcare Global Opioids Drug Market Insights, Forecast to 2025

  • RnM3115758
  • |
  • 15 March, 2019
  • |
  • Global
  • |
  • 118 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global Opioids Drug Market Insights, Forecast to 2025

Table of Contents

    1 Study Coverage

    • 1.1 Opioids Drug Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Opioids Drug Market Size Growth Rate by Product
      • 1.4.2 Oxycodone
      • 1.4.3 Hydromorphone
      • 1.4.4 Codeine
      • 1.4.5 Fentanyl
      • 1.4.6 Other
    • 1.5 Market by End User
      • 1.5.1 Global Opioids Drug Market Size Growth Rate by End User
      • 1.5.2 Pain Relief
      • 1.5.3 Anesthesia
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Opioids Drug Market Size
      • 2.1.1 Global Opioids Drug Revenue 2014-2025
      • 2.1.2 Global Opioids Drug Sales 2014-2025
    • 2.2 Opioids Drug Growth Rate by Regions
      • 2.2.1 Global Opioids Drug Sales by Regions
      • 2.2.2 Global Opioids Drug Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Opioids Drug Sales by Manufacturers
      • 3.1.1 Opioids Drug Sales by Manufacturers
      • 3.1.2 Opioids Drug Sales Market Share by Manufacturers
      • 3.1.3 Global Opioids Drug Market Concentration Ratio (CR5 and HHI)
    • 3.2 Opioids Drug Revenue by Manufacturers
      • 3.2.1 Opioids Drug Revenue by Manufacturers (2014-2019)
      • 3.2.2 Opioids Drug Revenue Share by Manufacturers (2014-2019)
    • 3.3 Opioids Drug Price by Manufacturers
    • 3.4 Opioids Drug Manufacturing Base Distribution, Product Types
      • 3.4.1 Opioids Drug Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Opioids Drug Product Type
      • 3.4.3 Date of International Manufacturers Enter into Opioids Drug Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Opioids Drug Sales by Product
    • 4.2 Global Opioids Drug Revenue by Product
    • 4.3 Opioids Drug Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Opioids Drug Breakdown Data by End User

    6 North America

    • 6.1 North America Opioids Drug by Countries
      • 6.1.1 North America Opioids Drug Sales by Countries
      • 6.1.2 North America Opioids Drug Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Opioids Drug by Product
    • 6.3 North America Opioids Drug by End User

    7 Europe

    • 7.1 Europe Opioids Drug by Countries
      • 7.1.1 Europe Opioids Drug Sales by Countries
      • 7.1.2 Europe Opioids Drug Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Opioids Drug by Product
    • 7.3 Europe Opioids Drug by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Opioids Drug by Countries
      • 8.1.1 Asia Pacific Opioids Drug Sales by Countries
      • 8.1.2 Asia Pacific Opioids Drug Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Opioids Drug by Product
    • 8.3 Asia Pacific Opioids Drug by End User

    9 Central & South America

    • 9.1 Central & South America Opioids Drug by Countries
      • 9.1.1 Central & South America Opioids Drug Sales by Countries
      • 9.1.2 Central & South America Opioids Drug Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Opioids Drug by Product
    • 9.3 Central & South America Opioids Drug by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Opioids Drug by Countries
      • 10.1.1 Middle East and Africa Opioids Drug Sales by Countries
      • 10.1.2 Middle East and Africa Opioids Drug Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Opioids Drug by Product
    • 10.3 Middle East and Africa Opioids Drug by End User

    11 Company Profiles

    • 11.1 Purdue Pharma
      • 11.1.1 Purdue Pharma Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Purdue Pharma Opioids Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Purdue Pharma Opioids Drug Products Offered
      • 11.1.5 Purdue Pharma Recent Development
    • 11.2 J&J
      • 11.2.1 J&J Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 J&J Opioids Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 J&J Opioids Drug Products Offered
      • 11.2.5 J&J Recent Development
    • 11.3 Teva
      • 11.3.1 Teva Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Teva Opioids Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Teva Opioids Drug Products Offered
      • 11.3.5 Teva Recent Development
    • 11.4 Mylan
      • 11.4.1 Mylan Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Mylan Opioids Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Mylan Opioids Drug Products Offered
      • 11.4.5 Mylan Recent Development
    • 11.5 Depomed
      • 11.5.1 Depomed Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Depomed Opioids Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Depomed Opioids Drug Products Offered
      • 11.5.5 Depomed Recent Development
    • 11.6 INSYS
      • 11.6.1 INSYS Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 INSYS Opioids Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 INSYS Opioids Drug Products Offered
      • 11.6.5 INSYS Recent Development
    • 11.7 Endo
      • 11.7.1 Endo Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Endo Opioids Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Endo Opioids Drug Products Offered
      • 11.7.5 Endo Recent Development
    • 11.8 Pfizer
      • 11.8.1 Pfizer Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Pfizer Opioids Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Pfizer Opioids Drug Products Offered
      • 11.8.5 Pfizer Recent Development
    • 11.9 Hikma
      • 11.9.1 Hikma Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Hikma Opioids Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Hikma Opioids Drug Products Offered
      • 11.9.5 Hikma Recent Development
    • 11.10 Mallinckrodt
      • 11.10.1 Mallinckrodt Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Mallinckrodt Opioids Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Mallinckrodt Opioids Drug Products Offered
      • 11.10.5 Mallinckrodt Recent Development
    • 11.11 Pernix
    • 11.12 Egalet
    • 11.13 Vistapharm

    12 Future Forecast

    • 12.1 Opioids Drug Market Forecast by Regions
      • 12.1.1 Global Opioids Drug Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Opioids Drug Revenue Forecast by Regions 2019-2025
    • 12.2 Opioids Drug Market Forecast by Product
      • 12.2.1 Global Opioids Drug Sales Forecast by Product 2019-2025
      • 12.2.2 Global Opioids Drug Revenue Forecast by Product 2019-2025
    • 12.3 Opioids Drug Market Forecast by End User
    • 12.4 North America Opioids Drug Forecast
    • 12.5 Europe Opioids Drug Forecast
    • 12.6 Asia Pacific Opioids Drug Forecast
    • 12.7 Central & South America Opioids Drug Forecast
    • 12.8 Middle East and Africa Opioids Drug Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Opioids Drug Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
      The classification of Opioids Drug includes Oxycodone, Hydromorphone, Codeine, Fentanyl and Other, and the revenue proportion of Oxycodone in 2016 is about 33%, and the proportion is in decreasing trend from 2012 to 2016.
      Opioids Drug is widely used for Pain Relief, Anesthesia and Other. The most proportion of Opioids Drug is for Pain Relief, and the proportion in 2016 is about 66.5%.
      North America is the largest supplier of Opioids Drug, with a production market share nearly 71% in 2016. Europe is the second largest supplier of Opioids Drug Media, enjoying production market share nearly 16% in 2016.
      North America is the largest consumption place, with a consumption market share nearly 60.5 % in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 20%.
      Market competition is not intense. Purdue Pharma, J&J, Teva, Mylan, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
      The global Opioids Drug market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Opioids Drug market based on company, product type, end user and key regions.

      This report studies the global market size of Opioids Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Opioids Drug in these regions.
      This research report categorizes the global Opioids Drug market by top players/brands, region, type and end user. This report also studies the global Opioids Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Purdue Pharma
      J&J
      Teva
      Mylan
      Depomed
      INSYS
      Endo
      Pfizer
      Hikma
      Mallinckrodt
      Pernix
      Egalet
      Vistapharm

      Market size by Product
      Oxycodone
      Hydromorphone
      Codeine
      Fentanyl
      Other
      Market size by End User
      Pain Relief
      Anesthesia
      Other

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Opioids Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Opioids Drug market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Opioids Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Opioids Drug submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Opioids Drug are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (M Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Opioids Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Opioids Drug . Industry analysis & Market Report on Opioids Drug is a syndicated market report, published as Global Opioids Drug Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Opioids Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,065.00
      4,597.50
      6,130.00
      3,494.44
      5,241.66
      6,988.89
      430,080.30
      645,120.45
      860,160.60
      271,964.55
      407,946.83
      543,929.10
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report